Volume 28, Number 12—December 2022
Research
Daily Rapid Antigen Exit Testing to Tailor University COVID-19 Isolation Policy
Table 2
Covariate | Sample size | ETR (95% CI) | p value |
---|---|---|---|
Time since last negative test, d | |||
<4† | 155 | NA | NA |
5–9 | 40 | 0.88 (0.77NA1.01) | 0.065 |
>10 |
68 |
0.85 (0.75NA0.96) |
0.008 |
Symptoms at diagnosis | |||
N | 104 | NA | Referent |
Y |
159 |
1.13 (1.02NA1.25) |
0.016 |
Ct value at diagnosis |
263 |
1 (0.99NA1) |
0.378 |
Prior infection >90 d | |||
N† | 244 | NA | NA |
Y |
19 |
0.5 (0.33NA0.76) |
0.001 |
No. dose/time since last dose | |||
2 doses / >5 mo† | 44 | NA | NA |
2 doses / <5 mo | 31 | 1.29 (0.97NA1.73) | 0.083 |
3 doses |
188 |
1.2 (1.04NA1.39) |
0.012 |
Primary vaccine brand | |||
Janssen/Johnson & Johnson† | 24 | NA | NA |
mRNA | 239 | 1.21 (0.89NA1.65) | 0.219 |
*N = 263 persons who were fully vaccinated with Pfizer-BioNTech (https://www.pfizer.com), Moderna (https://modernatx.com), or Janssen/Johnson & Johnson (https://jnj.com), did not additionally receive an international vaccine, and did not have a missing Ct value or symptom status. ETR >1 is associated with prolonged RAT positivity duration compared to the reference group. An ETR <1 is associated with a decreased RAT positivity duration. Ct, cycle threshold; Dx, diagnosis; ETR, event time ratio; mRNA, either of the mRNA vaccines from Pfizer or Moderna; NA, not applicable; RAT, rapid antigen test.
1These authors contributed equally to this article.
2Members of the team are listed at the end of this article.
Page created: November 08, 2022
Page updated: November 21, 2022
Page reviewed: November 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.